Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of adjuvanted pandemic H1N1 candidate vaccine schedules in infants aged 8 to 12 weeks
2009-015174-35Phase 2Terminated
- Sponsor
- GSK
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Q-Pan H1N1 in Influenza A infection (2 arms), sponsored by GSK. Primary endpoint: Safety and reactogenicity two weeks after Dose 1. Started Oct 2009; status: terminated.
02
Drugs
Q-Pan H1N1
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2009-015174-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015174-35.